Clinical Cancer Research
Clinical Cancer Research
5 years ago

Prediction of chemotherapeutic efficacy in non-small cell lung cancer by serum metabolomic profiling.

Zhijie Wang, Shugeng Gao, Di Wang, Jianchun Duan, Liangliang Cai, Yanhua Tian, Xue Zhang, Jie He, Hua Bai, Jie Wang, Jie-Fei Han, Cong Zhang, Zhaoli Chen, Jun Jiang, Jin Gu, Rui Wan, Yuxin Yin, Guoshuang Feng, Xiaohui Liu, Jia Liu
No validated biomarkers that could identify the subset of patients with lung adenocarcinoma who might benefit from chemotherapy have yet been well established. This study aimed to explore potential biomarker model predictive of efficacy and survival outcomes after first-line pemetrexed plus platinum doublet based on metabolomics profiling.

Publisher URL: http://doi.org/10.1158/1078-0432.CCR-17-2855

DOI: 10.1158/1078-0432.CCR-17-2855

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.